聯昌國際上調龍光集團評級至“買入”:多盤開售,流動性充裕
格隆匯2月8日丨聯昌國際最新研究報吿指出,隨着新加坡和香港3大標杆項目相繼落成和開售,龍光集團(03380.HK)將持續釋放現金流,增厚境外資金,有助於進一步鞏固公司流動性充裕優勢。近期,公司提前購回2022年未到期美元票據,持續增強資本市場信心。該機構上調龍光集團評級至“買入”。2021年龍光集團銷售實現逆週期增長,全年權益合約銷售額為1402億元,同比增長16.2%。2022開年,上海龍光•天境項目推盤311套房源當日售罄,銷售金額約40億元。業績穩健之外,龍光集團近期多筆債券的發行連續獲批,融資渠道保持續暢通,顯示出公司充裕的資金流動性以及良好的信用記錄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.